The value of plasma hypoxia markers for predicting imaging-based hypoxia in patients with head-and-neck cancers undergoing definitive chemoradiation

BACKGROUND: Tumor hypoxia worsens the prognosis of head-and-neck squamous cell carcinoma (HNSCC) patients, and plasma hypoxia markers may be used as biomarkers for radiotherapy personalization. We therefore investigated the role of the hypoxia-associated plasma proteins osteopontin, galectin-3, vasc...

Descripción completa

Detalles Bibliográficos
Autores principales: Rühle, Alexander, Grosu, Anca-L., Wiedenmann, Nicole, Ruf, Juri, Bieber, Birgit, Stoian, Raluca, Thomsen, Andreas R., Gkika, Eleni, Vaupel, Peter, Baltas, Dimos, Weber, Wolfgang A., Mix, Michael, Nicolay, Nils H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8881198/
https://www.ncbi.nlm.nih.gov/pubmed/35243023
http://dx.doi.org/10.1016/j.ctro.2022.02.008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8881198/
https://www.ncbi.nlm.nih.gov/pubmed/35243023
http://dx.doi.org/10.1016/j.ctro.2022.02.008

Ejemplares similares